Israeli researchers optimistic about COVID-19 breathalyser test

Israeli researchers optimistic about  COVID-19 breathalyser test
Cheryl Guttman Krader
Cheryl Guttman Krader
Published: Friday, May 29, 2020
[caption id="attachment_20134" align="alignleft" width="590"] Image by piotrpiotrwojcicki from Pixabay[/caption] TeraGroup, an Israeli company, is working with the Israeli Ministry of Defense Administration for the Development of Weapons and Technological Infrastructure (MAFAT) to develop a breathalyser test for COVID-19. In a recent television news segment, researchers involved in the project reported that they are making promising progress. The technology uses terahertz frequencies and generates a result within 60 seconds. Individuals perform the test by taking a deep breath and then exhaling into a tube three times.  Presence of the coronavirus within the exhaled breath aerosols is determined based on recognition of its spectral signature. In addition to its benefits for providing an immediate result and avoiding any laboratory processing, the test has the advantage of eliminating the need for both a skilled individual to obtain the sample and swabs, which have been in limited supply in some areas. According to one of the researchers, the breathalyser test may also detect the virus within the first four days after initial exposure, which is a window of time when results from polymerase chain reaction testing may be inaccurate. The developers believe that by identifying people who are not carrying the SARS-CoV-2 virus that causes COVID-19, the test will allow workers to return to their jobs and thereby assist in mobilising the economy.  They describe the breathalyser test as “the new thermometer”. Amir Tirosh MD, PhD, Director of the Endocrine Institute, Sheba Medical Center, Ramat Gan, Israel, said that this project can change how the world copes with the COVID-19 pandemic. “If we are debating whether to open the economy, how much to open, and how safe will it be, this changes the rules of the game,” said Dr Tirosh. The terahertz technology was being used for gender detection in avian eggs. It became the focus for developing a diagnostic test for COVID-19 within just a few days after government leaders and representatives from MAFAT decided to begin thinking outside of the box to come up with ideas for fighting the pandemic, including by looking at the potential of technologies that were already available on the market. The performance of the breathalyser test is being investigated at the Magen David Adom drive-through testing site in Jerusalem. Individuals who arrived for a traditional swab test at that centre were first asked to blow into the breathalyser’s collection tube.
Tags: covid-19 research
Latest Articles
Nutrition and the Eye: A Recipe for Success

A look at the evidence for tasty ways of lowering risks and improving ocular health.

Read more...

New Award to Encourage Research into Sustainable Practices

Read more...

Sharing a Vision for the Future

ESCRS leaders update Trieste conference on ESCRS initiatives.

Read more...

Extending Depth of Satisfaction

The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.

Read more...

Conventional Versus Laser-Assisted Cataract Surgery

Evidence favours conventional technique in most cases.

Read more...

AI Scribing and Telephone Management

Automating note-taking and call centres could boost practice efficiency.

Read more...

AI Analysis and the Cornea

A combination of better imaging and AI deep learning could significantly improve corneal imaging and diagnosis.

Read more...

Cooking a Feast for the Eyes

A cookbook to promote ocular health through thoughtful and traditional cuisine.

Read more...

Need to Know: Spherical Aberration

Part three of this series examines spherical aberration and its influence on higher-order aberrations.

Read more...

Generating AI’s Potential

How generative AI impacts medicine, society, and the environment.

Read more...